Antitumor activity | All | 10-20% (n=35) | > 20% (n=13) |
---|---|---|---|
Objective response | 39 (81.3, 70.2-92.3) | 26 (74.3, 56.7-87.5) | 13 (100, 75.3-100) |
Best overall response | |||
 Complete response | 5 (10.4) | 5 (14.3) | 0 (0) |
 Partial response | 34 (70.8) | 21 (60.0) | 13 (100) |
 Stable disease | 5 (10.4) | 5 (14.3) | 0 (0) |
 Progressive disease | 2 (4.2) | 2 (5.7) | 0 (0) |
 Unknown | 2 (4.2)* | 2 (5.7) | 0 (0) |